Published in Cancer Vaccine Week, January 16th, 2012
"Angelan increased the expression of MHC-I/II, CD80, and CD86, DC maturation markers, through the NF-kappa B pathway. This compound also increased CCR7 expression in DCs through NF-kappa B and p38 pathway and enhanced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Vaccine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.